vs
DiamondRock Hospitality Co（DRH）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
DiamondRock Hospitality Co的季度营收约是Ultragenyx Pharmaceutical Inc.的1.2倍（$258.2M vs $207.3M），DiamondRock Hospitality Co净利率更高（5.6% vs -62.0%，领先67.6%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 1.3%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -8.6%）
DiamondRock Hospitality Co是一家总部位于美国的房地产投资信托企业，持有并运营一系列高端酒店及度假物业，项目主要分布在全美核心城市的商务及旅游集聚区，面向休闲旅客和商务客群提供高品质住宿服务。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
DRH vs RARE — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $258.2M | $207.3M |
| 净利润 | $14.5M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 11.1% | -54.7% |
| 净利率 | 5.6% | -62.0% |
| 营收同比 | 1.3% | 25.9% |
| 净利润同比 | 22.0% | 3.5% |
| 每股收益（稀释后） | $0.07 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q1 26 | $258.2M | — | ||
| Q4 25 | $274.5M | $207.3M | ||
| Q3 25 | $285.4M | $159.9M | ||
| Q2 25 | $305.7M | $166.5M | ||
| Q1 25 | $254.9M | $139.3M | ||
| Q4 24 | $279.1M | $164.6M | ||
| Q3 24 | $285.1M | $139.5M | ||
| Q2 24 | $309.3M | $147.0M |
| Q1 26 | $14.5M | — | ||
| Q4 25 | $26.2M | $-128.6M | ||
| Q3 25 | $22.5M | $-180.4M | ||
| Q2 25 | $40.8M | $-115.0M | ||
| Q1 25 | $11.9M | $-151.1M | ||
| Q4 24 | $-11.2M | $-133.2M | ||
| Q3 24 | $26.4M | $-133.5M | ||
| Q2 24 | $24.5M | $-131.6M |
| Q1 26 | 11.1% | — | ||
| Q4 25 | 8.9% | -54.7% | ||
| Q3 25 | 8.1% | -106.9% | ||
| Q2 25 | 13.7% | -64.8% | ||
| Q1 25 | 4.3% | -102.6% | ||
| Q4 24 | -3.7% | -74.3% | ||
| Q3 24 | 9.5% | -94.6% | ||
| Q2 24 | 8.4% | -79.1% |
| Q1 26 | 5.6% | — | ||
| Q4 25 | 9.5% | -62.0% | ||
| Q3 25 | 7.9% | -112.8% | ||
| Q2 25 | 13.4% | -69.0% | ||
| Q1 25 | 4.7% | -108.5% | ||
| Q4 24 | -4.0% | -80.9% | ||
| Q3 24 | 9.3% | -95.7% | ||
| Q2 24 | 7.9% | -89.5% |
| Q1 26 | $0.07 | — | ||
| Q4 25 | $0.12 | $-1.28 | ||
| Q3 25 | $0.10 | $-1.81 | ||
| Q2 25 | $0.18 | $-1.17 | ||
| Q1 25 | $0.04 | $-1.57 | ||
| Q4 24 | $-0.06 | $-1.34 | ||
| Q3 24 | $0.11 | $-1.40 | ||
| Q2 24 | $0.10 | $-1.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $39.3M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.4B | $-80.0M |
| 总资产 | $3.0B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q1 26 | $39.3M | — | ||
| Q4 25 | $68.1M | $421.0M | ||
| Q3 25 | $145.3M | $202.5M | ||
| Q2 25 | $52.4M | $176.3M | ||
| Q1 25 | $100.6M | $127.1M | ||
| Q4 24 | $81.4M | $174.0M | ||
| Q3 24 | $75.3M | $150.6M | ||
| Q2 24 | $125.2M | $480.7M |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.2B | — |
| Q1 26 | $1.4B | — | ||
| Q4 25 | $1.4B | $-80.0M | ||
| Q3 25 | $1.6B | $9.2M | ||
| Q2 25 | $1.6B | $151.3M | ||
| Q1 25 | $1.6B | $144.2M | ||
| Q4 24 | $1.6B | $255.0M | ||
| Q3 24 | $1.6B | $346.8M | ||
| Q2 24 | $1.6B | $432.4M |
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $1.5B | ||
| Q3 25 | $3.1B | $1.2B | ||
| Q2 25 | $3.1B | $1.3B | ||
| Q1 25 | $3.1B | $1.3B | ||
| Q4 24 | $3.2B | $1.5B | ||
| Q3 24 | $3.2B | $1.5B | ||
| Q2 24 | $3.2B | $1.6B |
| Q1 26 | — | — | ||
| Q4 25 | 0.76× | — | ||
| Q3 25 | 0.70× | — | ||
| Q2 25 | 0.65× | — | ||
| Q1 25 | 0.70× | — | ||
| Q4 24 | 0.69× | — | ||
| Q3 24 | 0.67× | — | ||
| Q2 24 | 0.71× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
| Q1 26 | — | — | ||
| Q4 25 | $67.9M | $-99.8M | ||
| Q3 25 | $74.6M | $-91.4M | ||
| Q2 25 | $73.6M | $-108.3M | ||
| Q1 25 | $27.6M | $-166.5M | ||
| Q4 24 | $75.8M | $-79.3M | ||
| Q3 24 | $61.7M | $-67.0M | ||
| Q2 24 | $55.7M | $-77.0M |
| Q1 26 | — | — | ||
| Q4 25 | $47.3M | $-100.8M | ||
| Q3 25 | $54.9M | $-92.7M | ||
| Q2 25 | $57.9M | $-110.7M | ||
| Q1 25 | $2.0M | $-167.8M | ||
| Q4 24 | $52.6M | $-79.5M | ||
| Q3 24 | $39.0M | $-68.6M | ||
| Q2 24 | $38.8M | $-79.0M |
| Q1 26 | — | — | ||
| Q4 25 | 17.2% | -48.6% | ||
| Q3 25 | 19.2% | -58.0% | ||
| Q2 25 | 18.9% | -66.5% | ||
| Q1 25 | 0.8% | -120.5% | ||
| Q4 24 | 18.9% | -48.3% | ||
| Q3 24 | 13.7% | -49.2% | ||
| Q2 24 | 12.5% | -53.7% |
| Q1 26 | — | — | ||
| Q4 25 | 7.5% | 0.5% | ||
| Q3 25 | 6.9% | 0.8% | ||
| Q2 25 | 5.1% | 1.5% | ||
| Q1 25 | 10.0% | 1.0% | ||
| Q4 24 | 8.3% | 0.1% | ||
| Q3 24 | 7.9% | 1.2% | ||
| Q2 24 | 5.5% | 1.4% |
| Q1 26 | — | — | ||
| Q4 25 | 2.59× | — | ||
| Q3 25 | 3.31× | — | ||
| Q2 25 | 1.80× | — | ||
| Q1 25 | 2.33× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.33× | — | ||
| Q2 24 | 2.27× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DRH
| Rooms | $164.1M | 64% |
| Food and beverage | $67.2M | 26% |
| Other | $26.9M | 10% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
